BSE Live
Jan 13, 11:25Prev. Close
1149.50
Open Price
1149.60
Bid Price (Qty.)
1151.90 (8)
Offer Price (Qty.)
1154.90 (8)
NSE Live
Jan 13, 11:25Prev. Close
1151.00
Open Price
1152.90
Bid Price (Qty.)
1152.90 (2)
Offer Price (Qty.)
1154.30 (5)
| Key Financial Ratios of Epigral (in Rs. Cr.) | Mar 20 | Mar 19 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 26.95 | 25.09 | |
| Diluted EPS (Rs.) | 19.17 | 20.37 | |
| Cash EPS (Rs.) | 37.61 | 57.51 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 89.66 | 68.42 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 89.66 | 68.42 | |
| Dividend / Share(Rs.) | 4.10 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 146.92 | 172.45 | |
| PBDIT/Share (Rs.) | 47.27 | 78.11 | |
| PBIT/Share (Rs.) | 36.61 | 64.97 | |
| PBT/Share (Rs.) | 33.93 | 58.82 | |
| Net Profit/Share (Rs.) | 26.95 | 44.38 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 32.17 | 45.29 | |
| PBIT Margin (%) | 24.91 | 37.67 | |
| PBT Margin (%) | 23.09 | 34.10 | |
| Net Profit Margin (%) | 18.34 | 25.73 | |
| Return on Networth / Equity (%) | 30.06 | 64.85 | |
| Return on Capital Employed (%) | 15.08 | 30.86 | |
| Return on Assets (%) | 8.79 | 17.50 | |
| Total Debt/Equity (X) | 1.18 | 1.30 | |
| Asset Turnover Ratio (%) | 47.94 | 0.83 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 0.50 | 1.44 | |
| Quick Ratio (X) | 0.32 | 1.21 | |
| Inventory Turnover Ratio (X) | 12.61 | 7.31 | |
| Dividend Payout Ratio (NP) (%) | 15.06 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 10.79 | 0.00 | |
| Earnings Retention Ratio (%) | 84.94 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 89.21 | 0.00 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | |
| Retention Ratios (%) | 84.93 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 |
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
11.11.2025
Epigral Standalone September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y